Skip to content

Contribution of the MEOPA in the Physiotherapy Care of Painful Articular Steepness Among Elderly

Contribution of the MEOPA in the Physiotherapy Care of Painful Articular Steepness Among Elderly

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02230007
Enrollment
6
Registered
2014-09-03
Start date
2013-09-18
Completion date
2015-02-24
Last updated
2026-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain Management and Care

Brief summary

The MEOPA is used to obtain an analgesia of the short-term painful acts. To the population of elderly patients, the therapeutic resources to control the passing pain require in their manipulation a certain caution and are not divested of side effects badly tolerated at this age. An alternative in the opioid presents all its interest. The MEOPA is here an alternative of choice in the care of these pains, in particular in case of pre-existent cognitive achievement, of polypathologies or of polymédication. The gas MEOPA administered to the mask could thus be an effective additive in the physiotherapy treatment of the elderly person. The main objective is to Assess the efficacy , in terms of recovery of the hip and knee joint articular amplitude, of 3 sessions of reeducation using MEOPA versus standard reeducation within a population of elderly patients presenting a pain during the physiotherapy treatment.

Interventions

DRUGMEOPA

3 sessions of reeducation using MEOPA

Sponsors

Centre Hospitalier Universitaire de Nice
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or female aged 65 years old or more * Patients having a prescription for physiotherapy * Absence of contraindication to MEOPA * Patients whose initial assessment show a passive articular deficit of at least a joint of hip or the knee and whose painful assessment is ≥ 5 or ≥ 2 during mobilisation on the validated scale Algoplus * Patients whose reeducation project established by the physiotherapist * Patients having agreed to participate in the study and having signed the consent * Subjects affiliated to the social security system

Exclusion criteria

* Patient requiring a ventilation in pure oxygen * Patient with a consciousness deterioration preventing his cooperation * Care under MEOPA during the period of the protocol and during the month which precedes * Increase of the dosage of morphine of less than 48 hours Patient under guardianship

Design outcomes

Primary

MeasureTime frameDescription
% of recovery of the hip and knee joint articular amplitude5 days% of recovery of the hip and knee joint articular amplitude during 5 days after 3 sessions of reeducation using MEOPA versus standard reeducation within a population of elderly patients presenting a pain during the physiotherapy treatment; measure % of recovery of the hip and knee joint articular amplitude two times : before the beginning of the session of reeducation and at the end of the session

Secondary

MeasureTime frameDescription
Measure of the pain5 daysPatient answer a questionnaire on his pain at the beginning of each session of reeducation (5 sessions)
Patients'satisfactionEnd of the period of care (up to 5 days)Patient answer a questionnaire on this satisfaction at the end of the period of care of the protocol.
Physiotherapists'satisfactionEnd of all the period of care (up to 5 days)Physiotherapists answer a questionnaire on this satisfaction of the use of the MEOPA

Countries

France

Contacts

PRINCIPAL_INVESTIGATORVéronique Mailland, MD

Centre Hospitalier Universitaire de Nice

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 17, 2026